Association of blood pressure after peritoneal dialysis initiation with the decline rate of residual kidney function in newly-initiated peritoneal dialysis patients.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 21 02 2021
accepted: 22 06 2021
entrez: 8 7 2021
pubmed: 9 7 2021
medline: 1 12 2021
Statut: epublish

Résumé

Lower blood pressure (BP) levels are linked to a slower decline of kidney function in patients with chronic kidney disease (CKD) without kidney replacement therapy. However, there are limited data on this relation in peritoneal dialysis (PD) patients. Here we evaluated the association of BP levels with the decline of residual kidney function (RKF) in a retrospective cohort study. We enrolled 228 patients whose PD was initiated between 1998 and 2014. RKF was measured as the average of creatinine and urea clearance in 24-hr urine collections. We calculated the annual decline rate of RKF by determining the regression line for individual patients. RKF is thought to decline exponentially, and thus we also calculated the annual decline rate of logarithmic scale of RKF (log RKF). We categorized the patients' BP levels at 3 months after PD initiation (BP3M) into four groups (Optimal, Normal & High normal, Grade 1 hypertension, Grade 2 & 3 hypertension) according to the 2018 European Society of Cardiology and European Society of Hypertension Guidelines for the management of arterial hypertension. The unadjusted, age- and sex-adjusted, and multivariable-adjusted decline rate of RKF and log RKF decreased significantly with higher BP3M levels (P for trend <0.01). Compared to those of the Optimal group, the multivariable-adjusted odds ratios (95% confidence interval) for the faster side of the median decline rate of RKF and log RKF were 4.04 (1.24-13.2) and 5.50 (1.58-19.2) in the Grade 2 and 3 hypertension group, respectively (p<0.05). Higher BP levels after PD initiation are associated with a faster decline in RKF among PD patients.

Sections du résumé

BACKGROUND
Lower blood pressure (BP) levels are linked to a slower decline of kidney function in patients with chronic kidney disease (CKD) without kidney replacement therapy. However, there are limited data on this relation in peritoneal dialysis (PD) patients. Here we evaluated the association of BP levels with the decline of residual kidney function (RKF) in a retrospective cohort study.
METHODS
We enrolled 228 patients whose PD was initiated between 1998 and 2014. RKF was measured as the average of creatinine and urea clearance in 24-hr urine collections. We calculated the annual decline rate of RKF by determining the regression line for individual patients. RKF is thought to decline exponentially, and thus we also calculated the annual decline rate of logarithmic scale of RKF (log RKF). We categorized the patients' BP levels at 3 months after PD initiation (BP3M) into four groups (Optimal, Normal & High normal, Grade 1 hypertension, Grade 2 & 3 hypertension) according to the 2018 European Society of Cardiology and European Society of Hypertension Guidelines for the management of arterial hypertension.
RESULTS
The unadjusted, age- and sex-adjusted, and multivariable-adjusted decline rate of RKF and log RKF decreased significantly with higher BP3M levels (P for trend <0.01). Compared to those of the Optimal group, the multivariable-adjusted odds ratios (95% confidence interval) for the faster side of the median decline rate of RKF and log RKF were 4.04 (1.24-13.2) and 5.50 (1.58-19.2) in the Grade 2 and 3 hypertension group, respectively (p<0.05).
CONCLUSIONS
Higher BP levels after PD initiation are associated with a faster decline in RKF among PD patients.

Identifiants

pubmed: 34237104
doi: 10.1371/journal.pone.0254169
pii: PONE-D-21-05795
pmc: PMC8266121
doi:

Substances chimiques

Creatinine AYI8EX34EU

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0254169

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Nephrol Dial Transplant. 1995 Dec;10(12):2295-305
pubmed: 8808229
Perit Dial Int. 2003 May-Jun;23(3):276-83
pubmed: 12938830
Nephrol Dial Transplant. 2009 Nov;24(11):3520-5
pubmed: 19491381
Nephrol Dial Transplant. 2005 Aug;20(8):1693-701
pubmed: 15899939
J Am Soc Nephrol. 2001 Oct;12(10):2158-2162
pubmed: 11562415
Cochrane Database Syst Rev. 2014 Jun 23;(6):CD009120
pubmed: 24953826
Kidney Int. 2007 Jan;71(2):159-66
pubmed: 17136030
Nephrol Dial Transplant. 2001 Nov;16(11):2207-13
pubmed: 11682669
Kidney Int. 2002 Aug;62(2):639-47
pubmed: 12110029
Nephrol Dial Transplant. 2009 Sep;24(9):2909-14
pubmed: 19225016
Ann Intern Med. 2015 Feb 17;162(4):258-65
pubmed: 25686166
Am J Kidney Dis. 2001 Jul;38(1):85-90
pubmed: 11431186
Nutrition. 1989 Sep-Oct;5(5):303-11; discussion 312-3
pubmed: 2520314
Am J Kidney Dis. 2000 Sep;36(3):646-61
pubmed: 10977801
Nephrol Dial Transplant. 2003 Apr;18(4):797-803
pubmed: 12637651
J Am Soc Nephrol. 2004 Apr;15(4):1061-70
pubmed: 15034110
Am J Kidney Dis. 1999 Mar;33(3):523-34
pubmed: 10070917
JAMA. 1992 Dec 2;268(21):3085-91
pubmed: 1433739
J Am Soc Nephrol. 1996 May;7(5):745-50
pubmed: 8738810
Ann Intern Med. 1995 Nov 15;123(10):754-62
pubmed: 7574193
Semin Dial. 2020 May;33(3):223-235
pubmed: 32285984
Am J Kidney Dis. 1993 Feb;21(2):184-8
pubmed: 8430680
J Am Soc Nephrol. 2002 May;13(5):1307-1320
pubmed: 11961019
Kidney Int. 2016 Dec;90(6):1348-1356
pubmed: 27717485
ASAIO Trans. 1991 Oct-Dec;37(4):598-604
pubmed: 1768496
Perit Dial Int. 2015 Jul-Aug;35(4):388-96
pubmed: 26228783
Perit Dial Int. 2000 Jul-Aug;20(4):429-38
pubmed: 11007375
Perit Dial Int. 1993;13 Suppl 2:S394-5
pubmed: 8399620
Perit Dial Int. 1999 Mar-Apr;19(2):138-42
pubmed: 10357184
Am J Kidney Dis. 2009 Jun;53(6):982-92
pubmed: 19339088
J Hypertens. 2018 Oct;36(10):1953-2041
pubmed: 30234752
Nephron. 1993;65(3):469-71
pubmed: 8290003
J Am Soc Nephrol. 2001 Nov;12(11):2450-2457
pubmed: 11675422

Auteurs

Yusuke Kuroki (Y)

Nephrology & Dialysis Center, Japanese Red Cross Fukuoka Hospital, Fukuoka, Japan.

Kei Hori (K)

Division of Nephrology, Munakata Medical Association Hospital, Fukuoka, Japan.

Kazuhiko Tsuruya (K)

Department of Nephrology, Nara Medical University, Nara, Japan.

Dai Matsuo (D)

Division of Nephrology, Munakata Medical Association Hospital, Fukuoka, Japan.

Koji Mitsuiki (K)

Nephrology & Dialysis Center, Japanese Red Cross Fukuoka Hospital, Fukuoka, Japan.

Hideki Hirakata (H)

Nephrology & Dialysis Center, Japanese Red Cross Fukuoka Hospital, Fukuoka, Japan.

Toshiaki Nakano (T)

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Takanari Kitazono (T)

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH